Imidazo[1,2-a]pyridine Scaffold as Prospective Therapeutic Agents

Author(s): Aakash Deep, Richa Kaur Bhatia, Ramanjot Kaur, Sanjiv Kumar, Upendra Kumar Jain, Harinder Singh, Sandeep Batra, Dinesh Kaushik, Pran Kishore Deb.

Journal Name: Current Topics in Medicinal Chemistry

Volume 17 , Issue 2 , 2017

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Imidazo[1,2-a]pyridine is one of the most potential bicyclic 5–6 heterocyclic rings that is recognized as a “drug prejudice” scaffold due to its broad range of applications in medicinal chemistry such as anticancer, antimycobacterial, antileishmanial, anticonvulsant, antimicrobial, antiviral, antidiabetic, proton pump inhibitor, insecticidal activities. This scaffold has also been represented in various marketed preparations such as zolimidine, zolpidem, alpidem. Therefore, several attempts were made to carry out the structural modifications of this scaffold to discover and develop novel therapeutic agents. This review provides a valuable insight into the research findings of wide range of derivatives of imidazo[1,2-a]pyridine scaffold leading to promising heterocyclic compounds which could be explored further for the synthesis of new derivatives as well as construction of potential drug-like chemical libraries for biological screening in search of new therapeutic agents.

Keywords: Imidazo[1, 2-a]pyridines, Antimicrobial, Anticancer, Anticonvulsant, Antiviral.

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 17
ISSUE: 2
Year: 2017
Page: [238 - 250]
Pages: 13
DOI: 10.2174/1568026616666160530153233
Price: $58

Article Metrics

PDF: 29
HTML: 5